Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Citycon Oyj cancels repurchased shares

CITYCON OYJ   Stock Exchange Release   14 January 2022 at 8:15 hrsCitycon Oyj (“Citycon” or the “Company”) has today, in line with the decision by the Board of Directors, cancelled 489,585 own shares of the Company, which were repurchased under the share buy-back programme.Prior to the cancellation of the own shares, there were in total 168,498,525 registered shares in Citycon. The cancellation of the own shares has been registered with the trade register maintained by the Finnish Patent and Registration Office today on 14 January 2022. After the cancellation, the total number of shares

Observe Medical acquires Biim Ultrasound to strengthen its global medtech platform

· Observe Medical will develop and commercialize proprietary, innovative medtech products to the global market · International distributor and partner network with a Nordic direct sales organization · The agreement is set to accelerate the global commercial roll-out of the combined portfolio, including Sippi® US market launch and the entry of Biim in Europe Oslo, January 14th, 2022 – Observe Medical ASA (OSE: OBSRV) ("Observe Medical" or the "Company"), a Nordic-based medtech company focused on developing and commercializing proprietary and innovative medtech products to the

Observe Medical ASA – Key information relating to the preferential rights issue

Reference is made to the stock exchange announcement published by Observe Medical ASA (the "Company") earlier today, on 14 January 2022, regarding the resolution by the Company's board of directors to propose that the Company carries out a share capital increase, by way of a fully underwritten rights issue, to raise gross proceeds of NOK 180 million (the "Rights Issue"). Date on which the terms and conditions of the preferential rights issue were announced: 14 January 2022 Last day including right: 4 February 2022 Ex-date: 7 February 2022 Record Date: 8 February 2022 Date of

OBSERVE MEDICAL ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING – FULLY UNDERWRITTEN RIGHTS ISSUE

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS STOCK EXCHANGE The board of directors of Observe Medical ASA ("Observe Medical" or the "Company") has resolved to propose that the Company carries out a share capital increase, by way of a fully underwritten rights issue, to raise

Selvaag Bolig ASA: Completed buyback of own shares for employee share purchase programmes

As announced 6 December 2021 Selvaag Bolig ASA initiated repurchase of up to 500 000 shares for the company’s incentive programmes. The buyback has been completed. From 11 January 2022 through 13 January 2022 the company bought 54 101 shares at an average price of NOK 53.30. See the attached documents for detailed information about the transactions made. The company has bought 500 000 shares since 7 December.    The buyback was carried out in accordance with the EU Market Abuse Regulation and Safe Harbour Regulation. Daily purchases were limited to a maximum of 25 per cent of the

Free Background Checks in Pennsylvania for Looking Up Public Records: The Best PA Criminal and Arrest Records Search Engines Online

Are you moving into a shared apartment, and are wondering if your new flatmate will be trouble? Perhaps you're concerned whether or not your potential date is who they claim to be. Continue reading to learn about the greatest background check providers available. A background check can provide you with a wealth of information about someone. So, if you want to know whether your spouse is cheating or which background check tool is ideal for the position, this article is for you. In Pennsylvania, background checks may be useful for determining an applicant's integrity. The Pennsylvania

Gram Car Carriers: USD 121 million equity private placement successfully completed

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OF AMERICA AND THE DISTRICT OF COLUMBIA) (THE “UNITED STATES”), AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Reference is made to the stock exchange notice by Gram Car Carriers ASA ("GCC" or the "Company") on 12 January 2022 regarding the terms for an

OEM International acquires Demesne Electrical Sales Limited Ireland

OEM International has today acquired Demesne Electrical in Ireland. Demesne is Ireland’s leading independent importer and distributor of electrical control, switchgear, energy saving & installation products. The company has a total revenue of € 20 million with operating profit of € 2,5 million. The head office is located in Dublin with branch offices in Cork in the south of Ireland and Dungannon in Northern Ireland. The company has a strong product portfolio based on long partnerships with many of Europe’s leading manufacturers.“Demesne, which has been active since 1977, enjoys a very

Nordea Bank Abp: Repurchase of own shares on 13.01.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares13.01.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 13.01.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number of Weighted average Total cost, EUR* **venue (MIC shares price / share, EUR* Code) **XSTO 352,470 11.35 4,002,019.87XHEL 234,102 11.33 2,652,890.68CEUX 338,040 11.34 3,833,924.97AQEU 36,505 11.35

Arctic Bioscience – Christer Valderhaug appointed new CEO

Arctic Bioscience, a biotech company developing and commercializing nutraceutical and pharmaceutical products based on the unique properties of bioactive marine compounds has appointed Christer L. Valderhaug as new CEO.Mr. Valderhaug (49) will join Arctic Bioscience from his position as partner and head of investments at the advisory firm Converto AS based in Ålesund, Norway. Converto supports top management and boards cross a range of industries, including marine growth companies with strategic, operational and financial initiatives to maximize value creation. At Arctic Bioscience, he will

Norway Royal Salmon ASA (NRS) - Mandatory notification of trade

Hatlebrekke Invest AS, close associate to Klaus Hatlebrekke, CEO of Norway Royal Salmon ASA, has today purchased 10,000 shares in Norway Royal Salmon ASA at a price of NOK 158.0281 per share. Ola Loe, CFO of Norway Royal Salmon ASA, has today purchased 10,000 shares in Norway Royal Salmon ASA at a price of NOK 158.0282 per share. Kauna AS, close associate to Anne Sofie, COO Business development of Norway Royal Salmon ASA, has today purchased 1,800 shares in Norway Royal Salmon ASA at a price of NOK 158.0311 per share. This notification has been made pursuant to the Securities

Ylva Sarby Westman leaves her position as deputy CEO and CFO of Castellum

Ylva Sarby Westman has informed the company that she has decided to leave her position as deputy CEO and CFO of Castellum at her own request. She has been employed by Castellum since December 2021 and will remain in her position while the recruitment of a new CFO progresses.The recruitment process for a new CFO begins immediately.   For further information, please contact: Anna-Karin Nyman, Director Communications, Castellum AB, + 46 70 206 75 62, anna-karin.nyman@castellum.se   About Castellum Castellum is one of the largest listed property companies in the Nordic region

ABG Sundal Collier appointed as liquidity provider for Embellence Group

Embellence Group AB (publ) ("Embellence") has entered into an agreement with ABG Sundal Collier ASA ("ABGSC") stating that ABGSC will act as a liquidity provider for the Embellence share. The commitment takes place within the framework of Nasdaq OMX's rules on liquidity providers and means that the liquidity provider quotas the volume of purchases and sales in order to promote the liquidity of the share. The commitment will begin on January 10, 2022.

EnginZyme Selected for Cleantech Group’s 100 List of Companies Committed to Taking Action on the Climate Crisis

Stockholm, Sweden – 13 January 2022: EnginZyme, a leading developer of cell-free biomanufacturing processes, out of over 10,000 entrepreneurs was named a 2022 Global Cleantech 100 Company  by Cleantech Group. The 100 companies on the list represent the private, independent and for-profit companies best positioned to deliver solutions that will take us from commitments to actions in the sprint to net zero.“We are dedicated to solving one of the fundamental challenges

#22-16 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 13.01.2022

United Bankers Plc NOTIFICATION 13.01.2022 at 18:30 UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 13.01.2022 Date 13.01.2022Exchange transaction BuyShare class UNITEDAmount 427Average price/share 14.6500 EURHighest price/share 14.6500 EURLowest price/share 14.6500 EURTotal price 6,255.55 EUR The shares held by United Bankers Plc on 13.01.2022: UNITED 59,543 On behalf of United Bankers Plc  Skandinaviska Enskilda Banken AB (Publ) Antti Salakka         Janne Tiihonen For

ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 13.01.2022

ALEXANDRIA PANKKIIRILIIKE OYJ NOTIFICATION 13.01.2022 at 18:30 EET ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 13.01.2022 Date 13.01.2022Exchange transaction BuyShare class ALEXAmount 120Average price/share 8.9000 EURHighest price/share 8.9000 EURLowest price/share 8.9000 EURTotal price 1,068.00 EUR The shares held by Alexandria Pankkiiriliike Oyj on 13.01.2022: ALEX 48,560 On behalf of Alexandria Pankkiiriliike Oyj  Skandinaviska Enskilda Banken AB (Publ)

#22-15 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Large international evaluation shows AI accurately diagnoses prostate cancer

Researchers at Karolinska Institutet in Sweden have together with international collaborators completed a comprehensive international validation of artificial intelligence (AI) for diagnosing and grading prostate cancer. The study, published in Nature Medicine, shows that AI systems can identify and grade prostate cancer in tissue samples from different countries equally well as pathologists. The results suggest AI systems are ready to be responsibly introduced as a complementary tool in prostate cancer care, researchers say.The international validation was performed via a competition

Protective gene variant against COVID-19 identified

An international metastudy led by researchers at Karolinska Institutet in Sweden has identified a specific gene variant that protects against severe COVID-19 infection. The researchers managed to pinpoint the variant by studying people of different ancestries, a feat they say highlights the importance of conducting clinical trials that include people of diverse descents. The results are published in the journal Nature Genetics.In addition to old age and certain underlying diseases, genetics can influence whether we become severely affected or only suffer mild illness from COVID-19. Previous

Corem issues green bonds of SEK 2,350 million and announces results from tender offer for the outstanding Klövern 2018/2022 SEK bonds

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT. THE DISTRIBUTION OF THIS DOCUMENT IN CERTAIN JURISDICTIONS (IN PARTICULAR, THE UNITED STATES AND

Nordea to implement an orderly Board Chair succession – Stephen Hester proposed to take over from Torbjörn Magnusson during 2022

Nordea Bank AbpStock exchange release - Inside Information13 January 2022 at 18.00 EET The Shareholders’ Nomination Board of Nordea Bank Abp proposes Stephen Hester as member of the Board of Directors from the next Annual General Meeting of Shareholders and as new Chair of the Board from 1 October 2022 onwards. Torbjörn Magnusson is proposed to continue as Chair of the Board until 30 September 2022 and thereafter as ordinary member of the Board.  The Nomination Board has for the past year worked on Board member recruitment with particular focus on an orderly and successful Board

Resolutions at the extraordinary general meeting in Instalco

At an extraordinary general meeting in Instalco AB (publ) today on 13 January 2022, it was resolved on a share split and amendment of the articles of association.The extraordinary general meeting resolved, in accordance with the board of directors’ proposal, to increase the number of shares in the company by dividing each share into five shares (a so called share split, 5:1). In order to enable the share split, the general meeting resolved to amend § 5 of the company’s articles of association stipulating the minimum and maximum number of shares in such a way that the number of shares in the

Camurus announces dosing initiated in Phase 3 trial of weekly setmelanotide in patients with genetic obesity disorder

Lund, Sweden — 13 January 2022 — Camurus (NASDAQ STO: CAMX) today announces that the company’s license partner Rhythm Pharmaceuticals has dosed the first patients in a Phase 3 trial evaluating weekly setmelanotide subcutaneous depot in patients six years of age and older with a rare genetic disease of obesity. “We are pleased with the progress of our collaboration with Rhythm and today’s announcement of the first dosing in a randomized controlled Phase 3 trial of our long-acting formulation of setmelanotide in patients with rare genetic obesity disorders.” says Dr. Fredrik Tiberg, CEO

There are no items matching the current filter
There are no more items matching the current filter
Back to top